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Future Direction:
• Expansion of groups for more extensive 
senescence profiles.
• Investigate other possible gene associations 
of NASH and MCD diet.
• Investigate the long-term effect of CBG on 
the liver 
• Effects of CBG on secondary organs 
(pancreas, spleen).
• The relationship between Cannabinoid 
receptors and NASH. 
Background:
• Non-alcoholic steatohepatitis (NASH) is characterized by 
extreme fibrosis and inflammation and is the advanced form 
of non-alcoholic fatty liver disease (NAFLD).
• Methionine-choline deficient (MCD) diet is known to 
propagate NASH over short periods of time. 
• Cannabigerol (CBG) is a non-psychoactive, uncontrolled 
cannabinoid that is available as a Hemp extract.
• CBG has shown anti-inflammatory and neuroprotective 
effects, but effects on NASH are unknown.
• Senescence is the process of cell aging and degradation and 
can be viewed as a negative in tissue.
Aims:
• Long Term Goal
• Evaluate the therapeutic potential of CBG on the 
progression of NASH by using the MCD diet to induce NASH 
in a mouse model.
• Specific Aim
• Evaluate the effects of CBG on cellular senescence.
Methods
• Animal
• Eight-week-old mice were housed for five weeks.
• MCD diet
• Mice were fed three times per week and separated into 
either control or MCD diets; fed for five weeks.
• CBG treatment and dosages
• CBG treatment was IP injected starting in the 4th week.
• Dosages: high (24.6 mg/kg/day), low (2.46 mg/kg/day).
• Senescence Staining
• Beta-galactosidase and Nuclear Fast Red Staining were 
utilized to visualize senescence and morphology.
• qRT-PCR
• Gene expression was assessed through qRT-PCR of 
associated genes (p15, p16, p21, p53). 
Increased Senescence in MCD Groups and Decreased Senescence with CBG  
Gene Expression of p15 and p16 Senescent Genes. Expression Increases in MCD 
Groups Compared to the Control. 
Gene Expression of p21 and p53 Senescent Genes
Figure 3. Beta-galactosidase (SA X-Gal) and Nuclear Fast Red staining's were obtained via frozen tissues and O.C.T Reagents. Control group tissues 
showed negligible levels of senescence or altered morphology. The MCD Vehicle and High CBG groups showed heightened levels of senescence 
compared to the control. The MCD Low CBG group showed decreased senescence compared to the MCD High or Vehicle.     
Figure 4.  PCR gene expression of p15 and p16. Relative levels of expression show decreased levels in control groups compared to MCD groups. 
MCD Low CBG groups displayed increased levels compared to MCD Vehicle. Levels decreased with MCD High CBG compared to Low CBG. 
Figure 5. PCR gene expression of p21 and p53. Levels of gene expression show decreased levels in MCD Low CBG compared to MCD Vehicle.
Expression increased with MCD High CBG relative to MCD Low CBG but remained below MCD Vehicle. Relative control levels remained low 
compared to MCD groups.  
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Summary:
• Senescence appears to decrease in MCD Low 
diets from staining.
• MCD diet induces greater gene expression of 
senescent genes relative to the control.
• Low dose of CBG supplementation decreased 
relative cellular senescence in p21 and p53 
genes. 
• Senescent gene expression increases in p15 
and p16 genes for MCD Low compared to 
Vehicle.
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Conclusion:
• Low CBG dose appears to show inhibition of 
cellular senescence compared to a vehicle in 
some cases. The overall association between 
senescence and MCD associated NASH is still 
to be determined.
• CBG inhibition of senescence could be better 








Figure 1. Schematic image 
of proposed hypothesis. 
Figure 2. Experimental design during five-
week duration of mouse treatments.
